GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BIO-FD&C Co Ltd (XKRX:251120) » Definitions » Peter Lynch Fair Value

BIO-FD&C Co (XKRX:251120) Peter Lynch Fair Value : ₩12,400.85 (As of May. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is BIO-FD&C Co Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, BIO-FD&C Co's PEG is 1. BIO-FD&C Co's 5-Year TTM EBITDA Growth Rate is 25. BIO-FD&C Co's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ₩496.03. Therefore, the Peter Lynch Fair Value for today is ₩12,400.85.

As of today (2024-05-27), BIO-FD&C Co's share price is ₩14300.00. BIO-FD&C Co's Peter Lynch fair value is ₩12,400.85. Therefore, BIO-FD&C Co's Price to Peter Lynch Fair Value Ratio for today is 1.15.


The historical rank and industry rank for BIO-FD&C Co's Peter Lynch Fair Value or its related term are showing as below:

XKRX:251120' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1.15   Med: 1.37   Max: 1.37
Current: 1.15


During the past 7 years, the highest Price to Peter Lynch Fair Value Ratio of BIO-FD&C Co was 1.37. The lowest was 1.15. And the median was 1.37.


XKRX:251120's Price-to-Peter-Lynch-Fair-Value is ranked better than
58.14% of 86 companies
in the Biotechnology industry
Industry Median: 1.61 vs XKRX:251120: 1.15

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


BIO-FD&C Co Peter Lynch Fair Value Historical Data

The historical data trend for BIO-FD&C Co's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-FD&C Co Peter Lynch Fair Value Chart

BIO-FD&C Co Annual Data
Trend Dec15 Dec16 Dec18 Dec19 Dec20 Dec21 Dec22
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - 9,800.03 12,400.80

BIO-FD&C Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BIO-FD&C Co's Peter Lynch Fair Value

For the Biotechnology subindustry, BIO-FD&C Co's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIO-FD&C Co's Price-to-Peter-Lynch-Fair-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BIO-FD&C Co's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where BIO-FD&C Co's Price-to-Peter-Lynch-Fair-Value falls into.



BIO-FD&C Co Peter Lynch Fair Value Calculation

BIO-FD&C Co's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 25 *496.034
=12,400.85

BIO-FD&C Co's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was ₩496.03.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


BIO-FD&C Co  (XKRX:251120) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 25 instead of 15 in this case.

BIO-FD&C Co's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=14300.00/12,400.85
=1.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIO-FD&C Co Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of BIO-FD&C Co's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


BIO-FD&C Co (XKRX:251120) Business Description

Traded in Other Exchanges
N/A
Address
30, Songdomirae-ro, Yeonsu-gu, 509-512, B07, A-dong, Smartvalley, Incheon, KOR
BIO-FD&C Co Ltd is engaged in dealing with anti-aging and health materials using sustainable bio-cultivation technology. Its products include Plant cell, Peptide, Herbal Extract and Biomolecule.

BIO-FD&C Co (XKRX:251120) Headlines

No Headlines